Promino Nutritional Sciences Inc. (CSE:MUSL)
Canada · Delayed Price · Currency is CAD 0.0250
-0.0050 (-16.67%)
Aug 10, 2026, 9:30 AM EST
CSE:MUSL Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.02 | 0.02 | 0.15 | 0 | 0 | 0.49 |
Short-Term Investments | 0 | 0 | 0.37 | - | - | - |
Cash & Short-Term Investments | 0.02 | 0.03 | 0.51 | 0 | 0 | 0.49 |
Cash Growth | -92.25% | -94.93% | 95163.82% | -84.35% | -99.30% | 462.59% |
Accounts Receivable | 0.01 | 0.01 | 0.03 | 0.01 | 0.11 | 0.16 |
Other Receivables | 0.02 | 0.02 | 0.13 | 0.04 | 0.78 | 0.27 |
Receivables | 0.03 | 0.03 | 0.16 | 0.06 | 0.9 | 0.43 |
Inventory | 0.31 | 0.12 | 0.69 | 0.01 | 1.45 | 3.19 |
Prepaid Expenses | 0.16 | 0.03 | 0.02 | 0.06 | 0.21 | 0.81 |
Total Current Assets | 0.53 | 0.2 | 1.38 | 0.13 | 2.56 | 4.92 |
Property, Plant & Equipment | - | - | - | 0.03 | 0.09 | 0.08 |
Total Assets | 0.53 | 0.2 | 1.38 | 0.16 | 2.65 | 5 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.74 | 5.79 | 5.51 | 5.33 | 5.67 | 2.97 |
Accrued Expenses | 0.1 | 0.14 | 0.4 | - | - | - |
Short-Term Debt | 0.38 | 0.41 | 0.39 | 0.5 | 0.7 | 0.22 |
Current Portion of Long-Term Debt | 1.68 | 1.64 | 1.68 | 2.24 | 0.94 | 0.47 |
Current Portion of Leases | - | - | - | 0.01 | 0.01 | - |
Other Current Liabilities | - | 0.13 | - | 0.5 | 0.18 | - |
Total Current Liabilities | 7.89 | 8.12 | 7.97 | 8.57 | 7.5 | 3.66 |
Long-Term Debt | - | - | 0.04 | 0.04 | - | 0.03 |
Long-Term Leases | - | - | - | 0.02 | 0.03 | - |
Total Liabilities | 7.89 | 8.12 | 8.02 | 8.63 | 7.52 | 3.69 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 36.98 | 33.25 | 32.54 | 24.99 | 23.98 | 20.45 |
Additional Paid-In Capital | 5.99 | 8.56 | 7.91 | 5.71 | 4.64 | - |
Retained Earnings | -49.65 | -49.24 | -46.24 | -38.91 | -33.1 | -22.76 |
Comprehensive Income & Other | -0.68 | -0.49 | -0.84 | -0.25 | -0.38 | 3.61 |
Total Common Equity | -7.36 | -7.92 | -6.63 | -8.47 | -4.87 | 1.3 |
Shareholders' Equity | -7.36 | -7.92 | -6.63 | -8.47 | -4.87 | 1.3 |
Total Liabilities & Equity | 0.53 | 0.2 | 1.38 | 0.16 | 2.65 | 5 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.05 | 2.06 | 2.11 | 2.8 | 1.67 | 0.72 |
Net Cash (Debt) | -2.04 | -2.03 | -1.6 | -2.8 | -1.67 | -0.23 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.02 | -0.02 | -0.07 | -0.04 | -0.01 |
Filing Date Shares Outstanding | 207.9 | 175.93 | 136.31 | 41.9 | 37.78 | 32.52 |
Total Common Shares Outstanding | 177.93 | 137.2 | 115.09 | 41.9 | 37.49 | 32.19 |
Working Capital | -7.36 | -7.92 | -6.59 | -8.44 | -4.94 | 1.26 |
Book Value Per Share | -0.04 | -0.06 | -0.06 | -0.20 | -0.13 | 0.04 |
Tangible Book Value | -7.36 | -7.92 | -6.63 | -8.47 | -4.87 | 1.3 |
Tangible Book Value Per Share | -0.04 | -0.06 | -0.06 | -0.20 | -0.13 | 0.04 |
Machinery | - | - | - | - | 0.23 | 0.2 |
Leasehold Improvements | - | - | - | - | 0 | 0.02 |